DV
Dange Veerapaneni
About Dange Veerapaneni
Data last updated:
Dange Veerapaneni is a Managing Director at Sparsha Pharma International Private Limited (since 2008). The company operates in Pharma. Sparsha Pharma International Private Limited reported revenue of ₹29.04 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sparsha Pharma International Private Limited U24232TG2007PTC052719 | Managing Director | 11 Apr 2008 | 2007 | ₹29.04 Cr (FY 2025) | Active |
Board colleagues of Dange Veerapaneni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bobba Venkatadri | 02272890 | Sparsha Pharma International Private Limited | Director |
| Hema Latha Devi Veerapaneni | 00225447 | Sparsha Pharma International Private Limited | Director |
| Hiroyuki Kubo | 08063523 | Sparsha Pharma International Private Limited | Director |
| J Sainathan | Sparsha Pharma International Private Limited | Company Secretary | |
| Jayaraman Sainathan | Sparsha Pharma International Private Limited | Company Secretary | |
| Rajini Telaprolu | 10412207 | Sparsha Pharma International Private Limited | Director |
| Shosaku Murayama | 02408044 | Sparsha Pharma International Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dange Veerapaneni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dange Veerapaneni
Dange Veerapaneni currently holds 1 directorship: Sparsha Pharma International Private Limited (Managing Director, since 11 Apr 2008, revenue ₹29.04 Cr (FY 2025)).
Dange Veerapaneni was first appointed on 11 Apr 2008 as Managing Director at Sparsha Pharma International Private Limited.
The current boards of Dange Veerapaneni's companies include Bobba Venkatadri (Sparsha Pharma International Private Limited), Hema Latha Devi Veerapaneni (Sparsha Pharma International Private Limited), Hiroyuki Kubo (Sparsha Pharma International Private Limited), J Sainathan (Sparsha Pharma International Private Limited), Jayaraman Sainathan (Sparsha Pharma International Private Limited), Rajini Telaprolu (Sparsha Pharma International Private Limited), among others.